THE USE OF AJMALIN FOR THE NORMALISATION OF THE W--P--W SYNDROME. (PRELIMINARY REPORT).
D000015:Abnormalities, Multiple; D019465:Craniofacial Abnormalities; D004358:Drug Therapy; D006801:Humans; D008607:Intellectual Disability; D011926:Rauwolfia; D014927:Wolff-Parkinson-White Syndrome
DRUG THERAPY; RAUWOLFIA; WOLFF-PARKINSON-WHITE SYNDROME